CN Stock MarketDetailed Quotes

Beijing Beilu Pharmaceutical (300016)

Watchlist
  • 9.30
  • -0.23-2.41%
Market Closed Apr 24 15:00 CST
5.23BMarket Cap56.36P/E (TTM)

Beijing Beilu Pharmaceutical (300016) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
22.54%1.21B
19.59%872.68M
23.27%584.21M
36.23%282.68M
10.42%983.55M
12.30%729.72M
8.20%473.93M
10.35%207.51M
16.30%890.72M
16.60%649.82M
Operating revenue
22.54%1.21B
19.59%872.68M
23.27%584.21M
36.23%282.68M
10.42%983.55M
12.30%729.72M
8.20%473.93M
10.35%207.51M
16.30%890.72M
16.60%649.82M
Other operating revenue
-10.62%9M
----
174.39%9.81M
----
56.86%10.07M
----
313.48%3.57M
----
44.96%6.42M
----
Total operating cost
17.75%1.16B
19.05%839.91M
22.52%553.85M
41.38%270.75M
3.51%980.95M
4.51%705.51M
1.74%452.06M
5.58%191.5M
19.91%947.67M
24.16%675.05M
Operating cost
26.91%653.18M
29.56%472.36M
32.39%309.24M
67.41%154.19M
9.04%514.66M
9.86%364.6M
5.67%233.59M
-6.45%92.11M
38.15%472.01M
44.72%331.88M
Operating tax surcharges
19.62%15.46M
21.26%11.21M
23.09%7.6M
35.47%3.65M
25.69%12.93M
8.63%9.24M
8.74%6.17M
49.61%2.69M
-10.15%10.29M
10.22%8.51M
Operating expense
7.47%261.52M
7.73%191.27M
13.66%128.35M
8.88%56.67M
12.12%243.35M
14.98%177.55M
10.50%112.93M
52.54%52.05M
3.08%217.05M
4.44%154.42M
Administration expense
4.24%92.63M
7.35%65.52M
11.51%43.66M
16.48%21.02M
8.72%88.86M
9.95%61.03M
6.66%39.15M
1.25%18.05M
-4.61%81.74M
-15.07%55.51M
Financial expense
-25.09%38.89M
-10.84%35.59M
4.85%25.97M
8.61%13.81M
17.29%51.91M
3.99%39.91M
-0.93%24.77M
4.78%12.72M
5.43%44.26M
32.98%38.38M
-Interest expense (Financial expense)
-31.43%39.78M
-15.52%37.19M
-2.21%27.54M
9.99%15.14M
9.16%58.01M
11.00%44.03M
10.94%28.16M
10.00%13.76M
11.53%53.14M
12.81%39.66M
-Interest Income (Financial expense)
20.22%-4.29M
29.34%-3.17M
37.69%-2.11M
-6.13%-1.79M
54.52%-5.38M
32.92%-4.48M
21.61%-3.39M
35.24%-1.68M
-39.34%-11.82M
-11.01%-6.68M
Research and development
34.88%93.39M
20.29%63.96M
10.09%39.03M
54.07%21.4M
-43.40%69.24M
-38.42%53.17M
-33.98%35.45M
-18.50%13.89M
23.55%122.33M
33.70%86.35M
Credit Impairment Loss
-732.67%-4.2M
-209.46%-2.18M
-410.86%-1.76M
9.53%963.46K
117.33%664.25K
213.47%1.99M
133.17%566.92K
143.39%879.63K
-598.64%-3.83M
-226.30%-1.76M
Asset Impairment Loss
7.98%-9.14M
-29.27%-4.89M
22.43%-2.5M
2.53%-813.01K
78.02%-9.93M
-0.86%-3.78M
6.10%-3.22M
-34.34%-834.08K
-89.72%-45.18M
-25.60%-3.75M
Other net revenue
1,976.29%60.07M
1,097.41%13.05M
114.26%181.15K
2,781.53%3.73M
92.64%-3.2M
-108.44%-1.31M
-115.10%-1.27M
-103.84%-139.04K
-489.15%-43.49M
-45.72%15.49M
Fair value change income
547.26%53.44M
138.94%5.24M
90.39%-855.71K
102.42%89K
14.39%-11.95M
-246.37%-13.45M
-236.13%-8.91M
-229.90%-3.68M
-153.19%-13.96M
-56.54%9.19M
Invest income
9.64%8.07M
17.38%6.74M
-73.79%990.76K
128.30%1.94M
22.80%7.36M
27.39%5.75M
4.16%3.78M
530.08%849.8K
205.20%5.99M
264.67%4.51M
-Including: Investment income associates
-233.30%-2.54M
-1,020.90%-1.68M
-438.31%-1.12M
-73.68%-644.59K
-138.92%-760.77K
-108.82%-149.73K
-70.70%330.16K
53.16%-371.13K
117.23%1.95M
185.91%1.7M
Asset deal income
-1,099.83%-1.23M
-69,732.88%-1.27M
-69,732.88%-1.27M
-69,909.93%-1.27M
-86.25%122.94K
-99.79%1.82K
-99.79%1.82K
--1.82K
801.04%894.31K
772.62%866.11K
Other revenue
24.71%13.13M
14.80%9.4M
-14.38%5.57M
6.45%2.82M
-16.39%10.53M
27.39%8.19M
158.83%6.51M
112.50%2.65M
-7.27%12.59M
-44.70%6.43M
Operating profit
18,608.32%110.28M
100.05%45.82M
48.22%30.54M
-1.27%15.66M
99.41%-595.83K
335.24%22.9M
874.88%20.6M
54.28%15.86M
-656.17%-100.44M
-123.10%-9.74M
Add:Non operating Income
-67.86%526.45K
-21.00%447.82K
287.88%389.95K
208.58%152.19K
-7.35%1.64M
-62.67%566.85K
-93.32%100.53K
92.12%49.32K
386.71%1.77M
3,896.51%1.52M
Less:Non operating expense
25.45%2.29M
-8.19%1.28M
228.42%874.29K
4,948.19%187.52K
-26.48%1.83M
71.99%1.4M
-51.01%266.21K
-88.33%3.71K
34.81%2.48M
-41.90%811.19K
Total profit
13,943.07%108.51M
103.78%44.98M
47.06%30.05M
-1.77%15.63M
99.23%-783.88K
344.49%22.08M
564.83%20.44M
54.82%15.91M
-585.25%-101.15M
-122.14%-9.03M
Less:Income tax cost
1,989.19%19.87M
79.66%5.52M
-40.52%3.11M
-45.79%2.32M
94.14%-1.05M
163.79%3.07M
378.17%5.24M
4,586.93%4.29M
-75.80%-17.95M
-253.02%-4.81M
Net profit
33,020.67%88.65M
107.68%39.47M
77.22%26.94M
14.47%13.3M
100.32%267.65K
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
Net profit from continuing operation
33,020.67%88.65M
107.68%39.47M
77.22%26.94M
14.47%13.3M
100.32%267.65K
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
Less:Minority Profit
69.47%-4.09M
12.61%-4.71M
30.22%-3.03M
-1,400.24%-1.24M
-16.96%-13.38M
12.43%-5.39M
6.54%-4.34M
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
Net profit of parent company owners
579.29%92.73M
81.10%44.18M
53.35%29.97M
26.13%14.54M
119.02%13.65M
1,156.34%24.39M
103.52%19.54M
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
Earning per share
Basic earning per share
500.00%0.18
75.05%0.087
50.00%0.06
25.96%0.0296
120.00%0.03
1,142.50%0.0497
100.00%0.04
-8.20%0.0235
-850.00%-0.15
-96.44%0.004
Diluted earning per share
100.00%0.18
----
28.57%0.09
16.14%0.0482
228.57%0.09
86.73%0.0999
40.00%0.07
-0.95%0.0415
-187.50%-0.07
-64.17%0.0535
Other composite income
Total composite income
33,020.67%88.65M
107.68%39.47M
77.22%26.94M
14.47%13.3M
100.32%267.65K
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
Total composite income of parent company owners
579.29%92.73M
81.10%44.18M
53.35%29.97M
26.13%14.54M
119.02%13.65M
1,156.34%24.39M
103.52%19.54M
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
Total composite income of minority owners
69.47%-4.09M
12.61%-4.71M
30.22%-3.03M
-1,400.24%-1.24M
-16.96%-13.38M
12.43%-5.39M
6.54%-4.34M
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue 22.54%1.21B19.59%872.68M23.27%584.21M36.23%282.68M10.42%983.55M12.30%729.72M8.20%473.93M10.35%207.51M16.30%890.72M16.60%649.82M
Operating revenue 22.54%1.21B19.59%872.68M23.27%584.21M36.23%282.68M10.42%983.55M12.30%729.72M8.20%473.93M10.35%207.51M16.30%890.72M16.60%649.82M
Other operating revenue -10.62%9M----174.39%9.81M----56.86%10.07M----313.48%3.57M----44.96%6.42M----
Total operating cost 17.75%1.16B19.05%839.91M22.52%553.85M41.38%270.75M3.51%980.95M4.51%705.51M1.74%452.06M5.58%191.5M19.91%947.67M24.16%675.05M
Operating cost 26.91%653.18M29.56%472.36M32.39%309.24M67.41%154.19M9.04%514.66M9.86%364.6M5.67%233.59M-6.45%92.11M38.15%472.01M44.72%331.88M
Operating tax surcharges 19.62%15.46M21.26%11.21M23.09%7.6M35.47%3.65M25.69%12.93M8.63%9.24M8.74%6.17M49.61%2.69M-10.15%10.29M10.22%8.51M
Operating expense 7.47%261.52M7.73%191.27M13.66%128.35M8.88%56.67M12.12%243.35M14.98%177.55M10.50%112.93M52.54%52.05M3.08%217.05M4.44%154.42M
Administration expense 4.24%92.63M7.35%65.52M11.51%43.66M16.48%21.02M8.72%88.86M9.95%61.03M6.66%39.15M1.25%18.05M-4.61%81.74M-15.07%55.51M
Financial expense -25.09%38.89M-10.84%35.59M4.85%25.97M8.61%13.81M17.29%51.91M3.99%39.91M-0.93%24.77M4.78%12.72M5.43%44.26M32.98%38.38M
-Interest expense (Financial expense) -31.43%39.78M-15.52%37.19M-2.21%27.54M9.99%15.14M9.16%58.01M11.00%44.03M10.94%28.16M10.00%13.76M11.53%53.14M12.81%39.66M
-Interest Income (Financial expense) 20.22%-4.29M29.34%-3.17M37.69%-2.11M-6.13%-1.79M54.52%-5.38M32.92%-4.48M21.61%-3.39M35.24%-1.68M-39.34%-11.82M-11.01%-6.68M
Research and development 34.88%93.39M20.29%63.96M10.09%39.03M54.07%21.4M-43.40%69.24M-38.42%53.17M-33.98%35.45M-18.50%13.89M23.55%122.33M33.70%86.35M
Credit Impairment Loss -732.67%-4.2M-209.46%-2.18M-410.86%-1.76M9.53%963.46K117.33%664.25K213.47%1.99M133.17%566.92K143.39%879.63K-598.64%-3.83M-226.30%-1.76M
Asset Impairment Loss 7.98%-9.14M-29.27%-4.89M22.43%-2.5M2.53%-813.01K78.02%-9.93M-0.86%-3.78M6.10%-3.22M-34.34%-834.08K-89.72%-45.18M-25.60%-3.75M
Other net revenue 1,976.29%60.07M1,097.41%13.05M114.26%181.15K2,781.53%3.73M92.64%-3.2M-108.44%-1.31M-115.10%-1.27M-103.84%-139.04K-489.15%-43.49M-45.72%15.49M
Fair value change income 547.26%53.44M138.94%5.24M90.39%-855.71K102.42%89K14.39%-11.95M-246.37%-13.45M-236.13%-8.91M-229.90%-3.68M-153.19%-13.96M-56.54%9.19M
Invest income 9.64%8.07M17.38%6.74M-73.79%990.76K128.30%1.94M22.80%7.36M27.39%5.75M4.16%3.78M530.08%849.8K205.20%5.99M264.67%4.51M
-Including: Investment income associates -233.30%-2.54M-1,020.90%-1.68M-438.31%-1.12M-73.68%-644.59K-138.92%-760.77K-108.82%-149.73K-70.70%330.16K53.16%-371.13K117.23%1.95M185.91%1.7M
Asset deal income -1,099.83%-1.23M-69,732.88%-1.27M-69,732.88%-1.27M-69,909.93%-1.27M-86.25%122.94K-99.79%1.82K-99.79%1.82K--1.82K801.04%894.31K772.62%866.11K
Other revenue 24.71%13.13M14.80%9.4M-14.38%5.57M6.45%2.82M-16.39%10.53M27.39%8.19M158.83%6.51M112.50%2.65M-7.27%12.59M-44.70%6.43M
Operating profit 18,608.32%110.28M100.05%45.82M48.22%30.54M-1.27%15.66M99.41%-595.83K335.24%22.9M874.88%20.6M54.28%15.86M-656.17%-100.44M-123.10%-9.74M
Add:Non operating Income -67.86%526.45K-21.00%447.82K287.88%389.95K208.58%152.19K-7.35%1.64M-62.67%566.85K-93.32%100.53K92.12%49.32K386.71%1.77M3,896.51%1.52M
Less:Non operating expense 25.45%2.29M-8.19%1.28M228.42%874.29K4,948.19%187.52K-26.48%1.83M71.99%1.4M-51.01%266.21K-88.33%3.71K34.81%2.48M-41.90%811.19K
Total profit 13,943.07%108.51M103.78%44.98M47.06%30.05M-1.77%15.63M99.23%-783.88K344.49%22.08M564.83%20.44M54.82%15.91M-585.25%-101.15M-122.14%-9.03M
Less:Income tax cost 1,989.19%19.87M79.66%5.52M-40.52%3.11M-45.79%2.32M94.14%-1.05M163.79%3.07M378.17%5.24M4,586.93%4.29M-75.80%-17.95M-253.02%-4.81M
Net profit 33,020.67%88.65M107.68%39.47M77.22%26.94M14.47%13.3M100.32%267.65K550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M
Net profit from continuing operation 33,020.67%88.65M107.68%39.47M77.22%26.94M14.47%13.3M100.32%267.65K550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M
Less:Minority Profit 69.47%-4.09M12.61%-4.71M30.22%-3.03M-1,400.24%-1.24M-16.96%-13.38M12.43%-5.39M6.54%-4.34M103.97%95.08K27.72%-11.44M52.87%-6.16M
Net profit of parent company owners 579.29%92.73M81.10%44.18M53.35%29.97M26.13%14.54M119.02%13.65M1,156.34%24.39M103.52%19.54M-8.35%11.53M-735.92%-71.76M-96.48%1.94M
Earning per share
Basic earning per share 500.00%0.1875.05%0.08750.00%0.0625.96%0.0296120.00%0.031,142.50%0.0497100.00%0.04-8.20%0.0235-850.00%-0.15-96.44%0.004
Diluted earning per share 100.00%0.18----28.57%0.0916.14%0.0482228.57%0.0986.73%0.099940.00%0.07-0.95%0.0415-187.50%-0.07-64.17%0.0535
Other composite income
Total composite income 33,020.67%88.65M107.68%39.47M77.22%26.94M14.47%13.3M100.32%267.65K550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M
Total composite income of parent company owners 579.29%92.73M81.10%44.18M53.35%29.97M26.13%14.54M119.02%13.65M1,156.34%24.39M103.52%19.54M-8.35%11.53M-735.92%-71.76M-96.48%1.94M
Total composite income of minority owners 69.47%-4.09M12.61%-4.71M30.22%-3.03M-1,400.24%-1.24M-16.96%-13.38M12.43%-5.39M6.54%-4.34M103.97%95.08K27.72%-11.44M52.87%-6.16M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor PwC China (Special General Partnership)------PwC China (Special General Partnership)------PwC China (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More